Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation

Experimental Hematology

Volumn 37, Issue 9, 2009, Pages 1022-1029

  Carvalho, Agostinho ^a   Cunha, Cristina ^a   Carotti, Alessandra ^a   Aloisi, Teresa ^a   Guarrera, Ornella ^a   Di Ianni, Mauro ^a   Falzetti, Franca ^a   Bistoni, Francesco ^a   Aversa, Franco ^a   Pitzurra, Lucia ^a   Rodrigues, Fernando ^b   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS PNEUMONIA;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INFECTION; MALE; MIDDLE AGED; MYCOSES; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRANSPLANTATION, HOMOLOGOUS;

CYTOMEGALOVIRUS; FUNGI;

EID: 68549110434     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.06.004     Document Type: Article

References (58)

1. Welniak L.A., Blazar B.R., and Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 25 (2007) 139-170
2. Cappellano P., Viscoli C., Bruzzi P., Van Lint M.T., Pereira C.A., and Bacigalupo A. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantation. New Microbiol 30 (2007) 89-99
3. Pagano L., Caira M., Nosari A., et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 45 (2007) 1161-1170
4. Bogunia-Kubik K., Wysoczanska B., and Lange A. Non-HLA gene polymorphisms and the outcome of allogeneic hematopoietic stem cell transplantation. Curr Stem Cell Res Ther 1 (2006) 239-253
5. Chen L., Wang T., Zhou P., et al. TLR engagement prevents transplantation tolerance. Am J Transplant 6 (2006) 2282-2291
6. Mayor N.P., Shaw B.E., Hughes D.A., et al. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol 25 (2007) 4262-4269
7. Schroder N.W., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5 (2005) 156-164
8. Schwartz D.A., and Cook D.N. Polymorphisms of the Toll-like receptors and human disease. Clin Infect Dis 41 Suppl 7 (2005) S403-S407
9. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
10. Lasker M.V., and Nair S.K. Intracellular TLR signaling: a structural perspective on human disease. J Immunol 177 (2006) 11-16
11. Lazarus R., Vercelli D., Palmer L.J., et al. Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 190 (2002) 9-25
12. Texereau J., Chiche J.D., Taylor W., Choukroun G., Comba B., and Mira J.P. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41 Suppl 7 (2005) S408-S415
13. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 5 (2006) 471-484
14. Vollmer J. TLR9 in health and disease. Int Rev Immunol 25 (2006) 155-181
15. Lazarus R., Klimecki W.T., Raby B.A., et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three US ethnic groups and exploratory case-control disease association studies. Genomics 81 (2003) 85-91
16. Torok H.P., Glas J., Tonenchi L., Bruennler G., Folwaczny M., and Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127 (2004) 365-366
17. Lorenz E., Schwartz D.A., Martin P.J., et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 384-387
18. Arbour N.C., Lorenz E., Schutte B.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
19. Michel O., LeVan T.D., Stern D., et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol 112 (2003) 923-929
20. Li H., and Sun B. Toll-like receptor 4 in atherosclerosis. J Cell Mol Med 11 (2007) 88-95
21. Ferwerda B., McCall M.B., Alonso S., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 104 (2007) 16645-16650
22. Romani L. Immunity to fungal infections. Nat Rev Immunol 4 (2004) 1-23
23. Morre S.A., Murillo L.S., Spaargaren J., Fennema H.S., and Pena A.S. Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis 186 (2002) 1377-1379 author reply 9
24. Van der Graaf C.A., Netea M.G., Morre S.A., et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 17 (2006) 29-34
25. Kesh S., Mensah N.Y., Peterlongo P., et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci 1062 (2005) 95-103
26. Bochud P.Y., Chien J.W., Marr K.A., et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359 (2008) 1766-1777
27. Land W.G. Innate immunity-mediated allograft rejection and strategies to prevent it. Transplant Proc 39 (2007) 667-672
28. Carvalho A., Marques A., Maciel P., and Rodrigues F. Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: A novel method applied to the analysis of the Portuguese population. Mol Cell Probes 21 (2007) 316-320
29. Carvalho A., Pasqualotto A.C., Pitzurra L., Romani L., Denning D.W., and Rodrigues F. Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 197 (2008) 618-621
30. Aversa F., Tabilio A., Velardi A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339 (1998) 1186-1193
31. Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23 (2005) 3447-3454
32. Tabilio A., Falzetti F., Giannoni C., et al. Stem cell mobilization in normal donors. J Hematother 6 (1997) 227-234
33. Ascioglu S., Rex J.H., Pauw d., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
34. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 (2008) 1813-1821
35. Ljungman P., Griffiths P., and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34 (2002) 1094-1097
36. Bozza S., Gaziano R., Bonifazi P., et al. Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol 19 (2007) 1261-1270
37. Tabeta K., Georgel P., Janssen E., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 101 (2004) 3516-3521
38. Delale T., Paquin A., Asselin-Paturel C., et al. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J Immunol 175 (2005) 6723-6732
39. Novak N., Yu C.F., Bussmann C., et al. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62 (2007) 766-772
40. Antequera F., Tamame M., Villanueva J.R., and Santos T. DNA methylation in the fungi. J Biol Chem 259 (1984) 8033-8036
41. Grohmann U., Volpi C., Fallarino F., et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13 (2007) 579-586
42. Bellocchio S., Montagnoli C., Bozza S., et al. The contribution of the Toll-Like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 172 (2004) 3059-3069
43. Ramirez-Ortiz Z.G., Specht C.A., Wang J.P., et al. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun 76 (2008) 2123-2129
44. Sun S., Rao N.L., Venable J., Thurmond R., and Karlsson L. TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allergy Drug Targets 6 (2007) 223-235
45. Kijpittayarit S., Eid A.J., Brown R.A., Paya C.V., and Razonable R.R. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 44 (2007) 1315-1320
46. Vanhinsbergh L.J., Powe D.G., and Jones N.S. Reduction of TLR2 gene expression in allergic and nonallergic rhinitis. Ann Allergy Asthma Immunol 99 (2007) 509-516
47. Dessing M.C., Schouten M., Draing C., Levi M., von Aulock S., and van der Poll T. Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. J Infect Dis 197 (2008) 245-252
48. Braedel S., Radsak M., Einsele H., et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol 125 (2004) 392-399
49. Chignard M., Balloy V., Sallenave J.M., and Si-Tahar M. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 124 (2007) 238-243
50. Mambula S.S., Sau K., Henneke P., Golenbock D.T., and Levitz S.M. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 277 (2002) 39320-39326
51. Netea M.G., Warris A., Van der Meer J.W., et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 188 (2003) 320-326
52. Candore G., Aquino A., Balistreri C.R., et al. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann N Y Acad Sci 1067 (2006) 282-287
53. Romani L., and Puccetti P. Controlling pathogenic inflammation to fungi. Expert Rev Anti Infect Ther 5 (2007) 1007-1017
54. Romani L., Fallarino F., De Luca A., et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451 (2008) 211-215
55. Romani L., Zelante T., De Luca A., Fallarino F., and Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 180 (2008) 5157-5162
56. De Luca A., Montagnoli C., Zelante T., et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 179 (2007) 5999-6008
57. Romani L., and Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol 14 (2006) 183-189
58. Trinchieri G., and Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7 (2007) 179-190